Related Experiment Video
Updated: Jan 6, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
Turkish Version of the Psychotropic Related Sexual Dysfunction Questionnaire (PRSEXDQ-T): Validity and Reliability in
The Turkish version of the Psychotropic Associated Sexual Dysfunction Questionnaire (PRSexDQ-T) is a valid and reliable tool for assessing sexual dysfunction in patients using selective serotonin reuptake inhibitors (SSRIs). This study confirms its utility in clinical practice.
Area of Science:
- Psychiatry
- Pharmacology
- Sexual Medicine
Background:
- Sexual dysfunctions (SD) are prevalent in psychiatric patients, often linked to illness or medication side effects.
- Existing scales struggle to differentiate SD causes (illness vs. medication).
- The Psychotropic Associated Sexual Dysfunction Questionnaire (PRSexDQ) was developed to screen for drug-induced SD.
Purpose of the Study:
- To validate and assess the reliability of the Turkish version of the PRSexDQ (PRSexDQ-T).
- To evaluate PRSexDQ-T's effectiveness in patients using selective serotonin reuptake inhibitors (SSRIs).
Main Methods:
- 100 psychiatric outpatients on SSRI treatment for at least one month were enrolled.
- Participants completed the PRSexDQ-T, Arizona Sexual Experience Scale (ASEX), and Golombok Rust Inventory Sexual Satisfaction (GRISS).
- Psychiatric evaluation was conducted by a psychiatrist.
Main Results:
- PRSexDQ-T demonstrated high internal consistency (Cronbach's Alpha = 0.906).
- Item-total correlations were high (above 0.7), and test-retest reliability was strong (0.939-0.985).
- Significant positive correlations were found between PRSexDQ-T, ASEX, and GRISS scores, supporting its validity.
Conclusions:
- The Turkish version of PRSexDQ is a valid and reliable instrument.
- PRSexDQ-T effectively measures sexual dysfunction levels in patients using SSRIs.
Related Concept Videos
Reliability and Validity
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Antidepressant Drugs: MAOIs and Other Agents
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Self-Report Tests of Personality
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

